Management of hypersensitivity reactions to enzyme replacement therapy in children with lysosomal storage diseases


Yagmur I. T. , Uzun Ö., Yavas A. K. , Celik I. K. , Toyran M., Gunduz M., ...More

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.125, no.4, pp.460-467, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 125 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.1016/j.anai.2020.07.010
  • Journal Name: ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, CAB Abstracts, CINAHL, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.460-467

Abstract

Background: Intravenous recombinant enzyme replacement therapy (ERT) is currently available for 8 lysosomal diseases. Hypersensitivity reactions (HSRs) may be observed during this long-term treatment.